Skip to main content
. 2020 Jul;16(4):192–207. doi: 10.22122/arya.v16i4.2123

Table 6.

Subgroup analysis of total cholesterol based on random effect analysis

Subgroup Effect size (n) WMD (95%CIs) P-within I2 (%) Q-test
Overall 13 -11.029 (-20.716, -1.342) 0.026 75.2 < 0.001
BMI
 Not detected 1 - - - -
 Normal 3 -28.929 (-51.346, -6.512) 0.011 82.0 0.004
 Overweight 7 0.768 (-7.330, 8.865) 0.853 10.8 0.347
 Obese 2 -13.829 (-31.573, 3.915) 0.127 13.0 0.284
Study quality
 Medium 7 -10.069 (-15.361, -4.778) < 0.001 0 0.851
 High 6 -10.920 (-34.218, 12.377) 0.358 89.0 < 0.001
Exercise duration
 Short 3 -15.156 (-33.558, 3.246) 0.106 59.5 0.084
 Medium 3 -0.053 (-17.385, 17.279) 0.995 48.8 0.142
 Long 7 -13.050 (-26.423, 0.323) 0.056 77.7 < 0.001
Exercise type
 AE 10 -10.438 (-23.481, 2.605) 0.117 78.4 < 0.001
 RE 1 7.730 (-17.014, 32.474) 0.540 - -
 AE+RE 2 -34.790 (-57.121, -12.459) 0.104 77.3 0.036
Exercise frequency
 1-2 times per week 3 -7.841 (18.089, 2.406) 0.134 0 0.732
 3-4 times per week 10 -12.133 (-24.723, 0.457) 0.059 81.0 < 0.001
Exercise volume
 Low 6 -4.435 (-13.602, 4.733) 0.343 0 0.761
 Moderate 4 -21.711 (-40.825, -2.598) 0.026 74.4 0.008
 High 3 -9.296 (-28.526, 9.935) 0.343 87.1 < 0.001

AE: Aerobic exercise; RE: Resistance exercise; WMD: Weighted mean difference (mg/dl); LDL: Low-density lipoprotein cholesterol; BMI: Body mass index

I2: Percent variation in WMD attributable to heterogeneity/ Q-test: Test for heterogeneity with significance of < 0.10/ P-Within: Test of WMD of sub-groups by random-effect model with significance of < 0.05